Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Songsong Liu

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 1 paper · 2020: 4 papers

Papers 10

  1. Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation. Co-author DOI 10.1016/j.ygeno.2020.11.010↗
  2. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Co-author DOI 10.1038/s41419-020-2617-7↗
  3. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.104091↗
  4. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription. Co-author DOI 10.7150/thno.44278↗
  5. miR-23a-5p inhibits cell proliferation and invasion in pancreatic ductal adenocarcinoma by suppressing ECM1 expression. Co-author PMID 31217868↗
  6. Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting PLK1 expression. Co-author DOI 10.1016/j.canlet.2018.02.014↗
  7. Retraction notice to "Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR-874-3p and inhibiting … Co-author DOI 10.1016/j.canlet.2018.09.027↗
  8. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Progn… Co-author DOI 10.1159/000495228↗
  9. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Co-author DOI 10.1016/j.canlet.2017.03.014↗
  10. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.19578↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 10 shared papers, 2017–2020 · strength 0.86
  2. Shixiang Guo · 6 shared papers, 2017–2020 · strength 0.50
  3. Yunchao Wang · 5 shared papers, 2017–2020 · strength 0.40
  4. Wenjie Huang · 4 shared papers, 2017–2019 · strength 0.33
  5. Bing Ni · 4 shared papers, 2017–2020 · strength 0.30
  6. Zhiping Zhao · 4 shared papers, 2017–2020 · strength 0.30
  7. Jianyou Gu · 3 shared papers, 2019–2020 · strength 0.29
  8. Huan Qin · 3 shared papers, 2017–2020 · strength 0.23
  9. Fuming Xie · 2 shared papers, 2020 · strength 0.20
  10. Junfeng Zhang · 2 shared papers, 2020 · strength 0.20
  11. Xianxing Wang · 2 shared papers, 2020 · strength 0.19
  12. Yingfang Fan · 2 shared papers, 2018 · strength 0.17
  13. Jiayun Ge · 2 shared papers, 2018–2020 · strength 0.17
  14. Yongsheng Ouyang · 2 shared papers, 2017–2020 · strength 0.16
  15. Jianyou Gu · 1 shared paper, 2020 · strength 0.10
  16. Hui Sun · 1 shared paper, 2020 · strength 0.10
  17. Yingfang Fan · 1 shared paper, 2019 · strength 0.10
  18. Tao Peng · 1 shared paper, 2020 · strength 0.10
  19. Xuejun Xu · 1 shared paper, 2020 · strength 0.10
  20. Yan Jiang · 1 shared paper, 2020 · strength 0.10
  21. Junfeng Zhang · 1 shared paper, 2020 · strength 0.10
  22. Jian Li · 1 shared paper, 2018 · strength 0.07
  23. Wenhua Li · 1 shared paper, 2018 · strength 0.07
  24. Yongkang Liu · 1 shared paper, 2018 · strength 0.07
  25. Yu You · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.